Xbrane Biopharma AB (SE0026598583) — research page
SE · se-cm-kg/XSTO/SE0026598583 · as of 2026-11-06
Identity and listing
The issuer is Xbrane Biopharma AB, listed on Nasdaq Stockholm under ticker SE0026598583, with ISIN SE0026598583 and LEI 5493008DKD05APTKQO39. Security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Xbrane Biopharma AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0026598583 | source · 2026-11-06 |
| ISIN | SE0026598583 | source · 2026-11-06 |
| LEI | 5493008DKD05APTKQO39 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 20 filings in the twelve months to 2026-11-06, across 15 filing days. The median gap between filing days is 9.0 days. The latest filing is dated 2026-10-30, 7 days before the record date, and is of type Interim report (Q1 and Q3). Exchange peers on Nasdaq Stockholm (398 issuers) show a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days. The sector median is not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 20 | 9 | 7 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-30 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Xbrane Biopharma releases Interim Report for January-September 2026 |
| 2026-10-27 | Inside information | Inside information | FDA approves Lucamzi™ - biosimilar to Lucentis® |
| 2026-10-23 | Investor News | Investor News | Invitation to presentation of Xbrane Biopharma's interim report January - September 2026 on October 30, 2026 |
| 2026-10-13 | Investor News | Investor News | Xbrane Announces Full Recruitment of Pivotal Clinical Trial for Xdivane™ |
| 2026-10-09 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | XBRANE BIOPHARMA PRESENTS THE NOMINATION COMMITTEE |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as the lifecycle type map for this register is not yet available.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the index does not yet carry a lifecycle type map for this register. The halt flag shows listed, not halted.
Orderability
The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1, as the chapter's orderability section, dated 2026-11-04, carries no client categories.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the date the live record began are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0026598583 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/XSTO/SE0026598583 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0026598583"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c2a1fa63a7cc1099.